4.8 Article

Aggregation-Induced-Emission Photosensitizer-Loaded Nano-Superartificial Dendritic Cells with Directly Presenting Tumor Antigens and Reversed Immunosuppression for Photodynamically Boosted Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy

Jing Liu et al.

Summary: This study reports a smart semiconducting polymer nano-immunomodulator that can achieve precise regulation of photodynamic immunotherapy for cancer in the acidic tumor microenvironment. The release of immunogenic factors and TLR7 agonist at the tumor site activates dendritic cells, leading to strong antitumor activities. Additionally, the nano-immunomodulator can directly eradicate tumors and induce immunogenic cancer cell death. This approach enhances systemic antitumor immune responses, resulting in inhibition of tumor growth and metastasis.

ADVANCED MATERIALS (2022)

Article Immunology

Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

Ellen Duong et al.

Summary: In this study, the researchers investigated the different roles of tumor-infiltrating dendritic cells (DCs) in anti-tumor immunity. By comparing spontaneously regressing and progressing tumors, they found that tumor-reactive CD8+ T cells were lost in progressing tumors but preserved in regressing tumors. They also identified a specific type of DCs (ISG(+) DCs) in regressing tumors that activated CD8+ T cells and played an important role in presenting tumor-derived antigens. Furthermore, they showed that exogenous IFN-b stimulation could restore the lost anti-tumor immunity in progressing tumors. These findings suggest that targeting this functional DC state may be a potential approach for the treatment of human diseases.

IMMUNITY (2022)

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

Editorial Material Biotechnology & Applied Microbiology

LAG3 pushes immuno-oncology's leading edge

Asher Mullard

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Engineering, Biomedical

Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

Shenwu Zhang et al.

Summary: Immunotherapy is a promising cancer treatment, but its efficacy for immune-cold tumors is not satisfactory. Photodynamic therapy can effectively induce immunogenic cell death, and the use of nanotechnology enhances the effectiveness of cancer immunotherapy. This article reviews recent advances in photodynamic therapy, nanotechnology, and immunogenic cell death, and discusses the prospects and challenges in this field.

BIOMATERIALS (2022)

Article Multidisciplinary Sciences

Programme of self-reactive innate-like T cell-mediated cancer immunity

Chun Chou et al.

Summary: A new class of tumor-infiltrating T cells (ILTCKs) has been identified, which are alpha beta T cell receptor (TCR)-positive and express FCER1G, with high cytotoxic potential. ILTCKs react broadly to unmutated self-antigens, arise from distinct thymic progenitors following early encounter with cognate antigens, and are continuously replenished by thymic progenitors during tumor progression. ILTCKs' expansion and effector differentiation depend on interleukin-15 (IL-15) expression in cancer cells, and inducible activation of IL-15 signaling suppresses tumor growth. This distinguishes ILTCKs from conventional cytotoxic T cells.

NATURE (2022)

Article Chemistry, Multidisciplinary

A Versatile 980 nm Absorbing Aggregation-Induced Emission Luminogen for NIR-II Imaging-Guided Synergistic Photo-Immunotherapy Against Advanced Pancreatic Cancer

Miao Wang et al.

Summary: A 980 nm absorbing agent, TPE-BT-BBTD, was developed for the treatment of advanced deep-seated tumors. The agent possesses deep near-infrared-II fluorescence imaging (NIR-II FLI) functionality and outstanding photothermal performance, making it suitable for advanced pancreatic cancer treatment. With the attachment of alpha PD-L1 antibody, alpha PD-L1@TPE-BT-BBTD nanoparticles demonstrate precise tumor targeting and excellent immunosuppression reversal ability. By inducing immunogenic tumor vaccination and enhancing cytotoxic T lymphocytes (CTLs) activity, the nanoparticles effectively suppress tumor growth and metastases.

ADVANCED FUNCTIONAL MATERIALS (2022)

Review Immunology

CD8+ T cell differentiation and dysfunction in cancer

Mary Philip et al.

Summary: The article discusses the dysfunctional states of CD8(+) T cells in tumors and their impact on response and resistance to immunotherapy. The authors emphasize the heterogeneity of T cell states in tumors and the challenge of predicting which patients will respond to immunotherapeutic interventions.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Chemistry, Multidisciplinary

NIR-II AIEgens: A Win-Win Integration towards Bioapplications

Wenhan Xu et al.

Summary: NIR-II AIEgens enabled by aggregation-induced emission luminogens have emerged as a promising field for high-performance imaging, overcoming limitations in penetration depth and fluorescence efficiency. Some NIR-II AIEgens demonstrate dual-mode imaging capabilities and guided photothermal therapy, improving diagnostic accuracy and providing an efficient platform for theranostics. This review highlights recent efforts in exploiting NIR-II AIEgens, discussing molecular design strategies, bioapplications, and presenting current challenges and future prospects for diverse applications.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Biochemical Research Methods

T cell antigen discovery

Alok V. Joglekar et al.

Summary: T cells respond to threats by recognizing short peptide antigens presented on MHC proteins using T cell receptors, which determines their function in disease. Recent method developments have made progress in T cell antigen discovery, but there are still challenges to overcome.

NATURE METHODS (2021)

Article Chemistry, Physical

A DNA nanodevice-based vaccine for cancer immunotherapy

Shaoli Liu et al.

Summary: A DNA nanodevice vaccine has been developed to stimulate a tumor-specific cytotoxic T lymphocyte response, leading to inhibition of tumor growth and prevention of metastasis. The vaccine utilizes molecular adjuvants and antigen peptides within a tubular DNA nanostructure to trigger T-cell activation and cancer cytotoxicity, showing promising results in mouse cancer models. The vaccination generates long-term T-cell responses which effectively protect against tumor rechallenge.

NATURE MATERIALS (2021)

Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Chemistry, Multidisciplinary

Conquering the Hypoxia Limitation for Photodynamic Therapy

Yilin Wan et al.

Summary: Photodynamic therapy (PDT) is a promising treatment modality due to its high spatiotemporal selectivity, minimal invasiveness, and low systemic toxicity, however, the hypoxic nature of many solid tumors limits its therapeutic effect. Efforts have been made to increase tumor oxygen content and alleviate tumor hypoxia through various strategies developed in the past decade, including delivering exogenous oxygen, generating oxygen in situ, reducing tumor cellular oxygen consumption, regulating the tumor microenvironment, and inhibiting the hypoxia-inducible factor 1 signaling pathway.

ADVANCED MATERIALS (2021)

Article Engineering, Biomedical

Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death

Zhihong Sun et al.

Summary: The study introduced a new potential anti-tumor immunotherapy method called intelligent DCs (iDCs), which utilize nanoparticles loaded with photothermal agents and coated with mature DC membrane technology. iDCs can stimulate T cells, reduce the expression of heat shock proteins in tumor cells, and induce immunogenic cell death through mild photothermal therapy, achieving a synergistic anti-tumor effect.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy

Ping Xiao et al.

Summary: Metabolic labeling of DCs is utilized to design nanoscale aAPCs that exhibit enhanced distribution in lymph nodes, activation of T cells and resident APCs, significant inhibition of tumor inoculation and growth, and improved efficacy when combined with PD1 therapy.

NANO LETTERS (2021)

Article Engineering, Biomedical

Mitochondrion-Anchored Photosensitizer with Near Infrared-I Aggregation-Induced Emission for Near Infrared-II Two-Photon Photodynamic Therapy

Zhenyan He et al.

Summary: A donor-pi-acceptor photosensitizer with near infrared aggregation-induced emission (AIE) is designed and synthesized for imaging-guided two-photon photodynamic therapy (2P-PDT), demonstrating precise cancer treatment through two-photon excitation in the NIR-II window.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Chemistry, Multidisciplinary

Combining Photothermal-Photodynamic Therapy Mediated by Nanomaterials with Immune Checkpoint Blockade for Metastatic Cancer Treatment and Creation of Immune Memory

Rita Lima-Sousa et al.

Summary: The combination of nanomaterial-mediated photothermal-photodynamic therapy with ICIs shows potential in targeting metastatic cancer by generating heat and reactive oxygen species within the tumor, modulating T cell populations, and inducing an anti-metastatic effect. This approach may also lead to the development of immune memory to prevent tumor recurrence.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Engineering, Biomedical

Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells

Longchao Liu et al.

Summary: A bispecific antibody targeting T-cell receptor CD3 epsilon and immune checkpoint PD-L1 on dendritic cells rejuvenates tumor-specific CD8 T cells, leading to durable antitumor responses in murine models of cancer.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Chemistry, Multidisciplinary

Second Near-Infrared Light-Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy

Cheng Xu et al.

Summary: Immunometabolic modulation through a second near-infrared (NIR-II) photothermally activatable semiconducting polymeric nanoantagonist (ASPA) provides a new approach for synergistic photothermal immunometabolic therapy of cancer. This remotely controlled immunometabolic regulation enhances cytotoxic T cell functions, suppresses regulatory T cell activities, and leads to efficient primary tumor inhibition, pulmonary metastasis prevention, and long-term immunological memory. This work offers a generic polymeric approach for precise spatiotemporal regulation of cancer immunometabolism.

ADVANCED MATERIALS (2021)

Review Chemistry, Multidisciplinary

Mito-Bomb: Targeting Mitochondria for Cancer Therapy

Xiaolu Guo et al.

Summary: Traditional cancer therapies such as surgery, chemotherapy, and radiotherapy have limited effectiveness, while photodynamic therapy, photothermal therapy, and chemodynamic therapy have shown promising results in cancer treatment due to their high selectivity, minimal resistance, and minimal toxicity.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

A Biomimetic Aggregation-Induced Emission Photosensitizer with Antigen-Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy

Xiuli Xu et al.

Summary: The biomimetic aggregation-induced emission (AIE) photosensitizers with antigen-presenting and hitchhiking abilities (DC@AIEdots) were developed by coating dendritic cell (DC) membranes on the nanoaggregates of the AIEgens. This technique can enhance tumor delivery efficiency by about 1.6 times and stimulate in vivo proliferation and activation of T cells. Additionally, a potential application of therapeutic agents targeting lipid droplets for immunotherapy is indicated, providing a new hitchhiking approach for drug delivery.

ADVANCED MATERIALS (2021)

Review Engineering, Biomedical

Recent Advances in Aggregation-Induced Emission Materials and Their Biomedical and Healthcare Applications

Wei He et al.

Summary: The emergence of aggregation-induced emission (AIE) concept has provided new opportunities in various research areas, particularly in biomedical fields. AIE luminogens possess numerous advantages and have been widely explored in biomedical applications. This review summarizes the latest advancements of AIE molecular probes and nanoparticles in biomedical and healthcare applications, discussing challenges and future opportunities in the advanced biomedical fields.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Chemistry, Multidisciplinary

Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs-Targeting Immunotherapy of Colon Cancer

Dongbing Ding et al.

Summary: By combining immunogenic photodynamic therapy with MDSC-targeting immunotherapy, the synergistic treatment effectively inhibits tumor growth while promoting immune responses to prevent tumor recurrence and metastasis.

ADVANCED SCIENCE (2021)

Review Oncology

Systemic immunity in cancer

Kamir J. Hiam-Galvez et al.

Summary: Understanding systemic immune landscape beyond the tumour microenvironment is crucial in assessing the effectiveness of immunotherapy in cancer treatment. Despite the potential of immunotherapy to induce new immune responses, compromised immune responses in individuals with tumors may limit its efficacy.

NATURE REVIEWS CANCER (2021)

Review Oncology

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

Suchit Jhunjhunwala et al.

Summary: This review discusses the importance of antigen presentation in the success of immune checkpoint inhibition therapy and mechanisms by which tumors evade immune recognition. Tumors evade immune recognition by modulating antigen expression and altering antigen presentation.

NATURE REVIEWS CANCER (2021)

Article Multidisciplinary Sciences

Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Keisuke Yamamoto et al.

NATURE (2020)

Review Biotechnology & Applied Microbiology

Targeting co-stimulatory molecules in autoimmune disease

Natalie M. Edner et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Oncology

Turning Cold into Hot: Firing up the Tumor Microenvironment

Qianqian Duan et al.

TRENDS IN CANCER (2020)

Review Oncology

Metabolism of immune cells in cancer

Robert D. Leone et al.

NATURE REVIEWS CANCER (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Chemistry, Multidisciplinary

Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Review Multidisciplinary Sciences

Harnessing innate immunity in cancer therapy

Olivier Demaria et al.

NATURE (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Immunology

Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor

Elisa Ruffo et al.

SEMINARS IN IMMUNOLOGY (2019)

Article Chemistry, Multidisciplinary

PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy

Xudong Zhang et al.

ADVANCED MATERIALS (2018)

Review Biochemistry & Molecular Biology

Nanoscale artificial antigen presenting cells for cancer immunotherapy

Kelly R. Rhodes et al.

MOLECULAR IMMUNOLOGY (2018)

Article Biotechnology & Applied Microbiology

Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells

Alexander S. Cheung et al.

NATURE BIOTECHNOLOGY (2018)

Review Immunology

Myeloid-derived suppressor cells coming of age

Filippo Veglia et al.

NATURE IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

Tingting Wang et al.

NATURE COMMUNICATIONS (2018)

Review Chemistry, Multidisciplinary

Photosensitizers with Aggregation-Induced Emission: Materials and Biomedical Applications

Fang Hu et al.

ADVANCED MATERIALS (2018)

Review Immunology

LAG3 (CD223) as a cancer immunotherapy target

Lawrence P. Andrews et al.

IMMUNOLOGICAL REVIEWS (2017)

Article Nanoscience & Nanotechnology

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

Yuanzeng Min et al.

NATURE NANOTECHNOLOGY (2017)

Review Chemistry, Multidisciplinary

AIE Luminogens for Bioimaging and Theranostics: from Organelles to Animals

Jun Qian et al.

Review Oncology

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

Danny N. Khalil et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Review Immunology

Dendritic Cells and Cancer Immunity

Alycia Gardner et al.

TRENDS IN IMMUNOLOGY (2016)

Review Immunology

Immunogenic Cell Death in Cancer Therapy

Guido Kroemer et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)